|
gptkbp:instanceOf
|
gptkb:company
|
|
gptkbp:acquiredBy
|
gptkb:Goldman_Sachs_Asset_Management
gptkb:EQT
gptkb:Veritas_Capital
|
|
gptkbp:acquisitionYear
|
2023
|
|
gptkbp:CEO
|
gptkb:Michelle_Keefe
|
|
gptkbp:formedByMergerOf
|
gptkb:INC_Research
gptkb:inVentiv_Health
|
|
gptkbp:founded
|
2017
|
|
gptkbp:headquartersLocation
|
gptkb:Morrisville,_North_Carolina,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Syneos Health
|
|
gptkbp:industry
|
clinical research
biopharmaceutical services
|
|
gptkbp:keyPerson
|
gptkb:Michael_Brooks
gptkb:Jason_Meggs
gptkb:Michelle_Keefe
|
|
gptkbp:logo
|
Syneos Health logo.svg
|
|
gptkbp:notableClient
|
pharmaceutical companies
biotechnology companies
medical device companies
|
|
gptkbp:numberOfEmployees
|
~28,000
|
|
gptkbp:parentCompany
|
private equity consortium (as of 2023)
|
|
gptkbp:previousName
|
gptkb:INC_Research/inVentiv_Health
|
|
gptkbp:revenue
|
$5.4 billion (2022)
|
|
gptkbp:servesArea
|
worldwide
|
|
gptkbp:services
|
clinical trials
consulting
commercial outsourcing
|
|
gptkbp:specialty
|
contract commercial organization (CCO)
contract research organization (CRO)
|
|
gptkbp:stockExchange
|
gptkb:NASDAQ
|
|
gptkbp:stockSymbol
|
gptkb:SYNH
|
|
gptkbp:type
|
private (after 2023)
public (until 2023)
|
|
gptkbp:website
|
https://www.syneoshealth.com/
|
|
gptkbp:bfsParent
|
gptkb:Advent_International
gptkb:Elliott_Management_Corporation
|
|
gptkbp:bfsLayer
|
6
|